About Bioline  All Journals  Testimonials  Membership  News  Donations

Journal of Applied Sciences and Environmental Management
World Bank assisted National Agricultural Research Project (NARP) - University of Port Harcourt
ISSN: 1119-8362
Vol. 16, No. 1, 2012, pp. 35-40
Bioline Code: ja12006
Full paper language: English
Document type: Research Article
Document available free of charge

Journal of Applied Sciences and Environmental Management, Vol. 16, No. 1, 2012, pp. 35-40

 en Use of Artemisinin- Combination Therapies in Port Harcourt
Shorinwa, O.A. & Omotayo, O.


Malaria still constitutes a public health problem in Nigeria and it is the leading cause of morbidity and mortality in Sub –Saharan Africa. The emergence and spread of Plasmodium falciparum check for this species in other resources parasite resistance to commonly used antimalarials such as chloroquine and sulphadoxine/pyrimethamine has posed challenges to malaria control. The World Health Organization (WHO) recommends the use of Artemisinin- based combination therapies (ACTs) as the first line of treatment for malaria in Sub –Saharan Africa. This study was carried out to determine the pattern of use of ACTs in Port Harcourt so as to identify problems associated with ACTS use and to contribute to malaria control programme in the country. The parameters investigated include the demography, frequency of malaria attacks, place of treatment, mode of treatment and specific antimalarial drug treatment. A survey was conducted with the aid of structured questionnaires in Port Harcourt metropolis. Of the 717 questionnaires that were returned and evaluated, 690 (96.2%) respondents claimed to have had malaria within the last one year; 244 (34%) received treatment from hospitals; 273 (38.1%) received treatment from pharmacies; 137 (19.1%) engaged in self medication and 17 (2.4%) received herbal treatment. The respondents that took artemisinin based combination drugs were 230 (32.1%), those that took artesunate only were 174 (24.3%), those that took chloroquine were 101 (14.1%) while those that took sulphadoxine/pyrimethamine were 140 (19.5%) while 72 (10%) took other antimalarial drugs. This study suggests that a majority of respondents in the study area take ACTs for the treatment of malaria.

Artemisinin-based combination therapy (ACT), Malaria, Antimalarial

© Copyright 2012 - Journal of Applied Sciences and Environmental Management

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2020, Site last up-dated on 29-Jan-2020.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Internet Data Center of Rede Nacional de Ensino e Pesquisa, RNP, Brazil